| 今开：15.92 | 昨收：15.77 |
| 最高：16.025 | 最低：14.63 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：4.8481367E8 |
Celcuity(CELC)02-08 06:25
$Celcuity(CELC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-005275 Act: 34 Size: 90 KB 网页链接查看全文
Celcuity(CELC)03-28 04:35
$Celcuity(CELC)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-24-011514 Act: 34 Size: 338 KB 网页链接查看全文
Celcuity(CELC)03-30 05:05
$Celcuity(CELC)$ ARS Annual Report to Security Holders Accession Number: 0001493152-24-012021 Act: 34 Size: 2 MB 网页链接查看全文
Celcuity(CELC)02-16 06:25
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-003326 Size: 25 KB 网页链接查看全文
Celcuity(CELC)02-16 06:35
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-003329 Size: 25 KB 网页链接查看全文
Celcuity(CELC)02-08 06:25
$Celcuity(CELC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-005274 Act: 34 Size: 73 KB 网页链接查看全文
Celcuity(CELC)今天 05:05
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-008888 Size: 14 KB 网页链接查看全文
Celcuity(CELC)02-15 05:15
$Celcuity(CELC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001493152-24-006620 Act: 34 Size: 93 KB 网页链接查看全文
Celcuity(CELC)02-15 09:35
$Celcuity(CELC)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-024203 Act: 34 Size: 221 KB 网页链接查看全文
Celcuity(CELC)04-11 04:45
$Celcuity(CELC)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-008275 Size: 22 KB 网页链接查看全文
新浪医药2021-04-09 13:15
编译丨river
4月8日，据外媒报道，细胞分析公司Celcuity宣布与辉瑞公司达成全球许可协议，辉瑞将gedatolisib（一种1b期pan-PI3K / mTOR抑制剂）专有权授予给Celcuity。Gedatolisib正在临床开发中，用于治疗ER + / HER2-阴性的晚期或转移性乳腺癌患者。
根据许可协议条款，辉瑞向Celcuity提...查看全文
美股 美股开盘 | 三大指数涨跌不一，搜狐(SOHU.US)涨超13% 2021年4月9日 20:31:45 智通财经APP获悉，4月9日(周五)美股开盘，三大指数涨跌不一。截至发稿，道指涨0.18%，标普500指数跌0.03%，纳指跌0.41%。 个股消息 细胞分析公司Celcuit... 网页链接
格隆汇4月9日丨Celcuity(CELC.US)盘前大涨38.78%报19.86美元。公司周四表示，已与辉瑞公司签署了一项全球许可协议，获得了开发和商业化辉瑞Gedatolisib的全球许可。Gedatolisib正处于临床开发阶段，用于治疗某些类型的乳腺癌患者。Celcuity表示:“来自103... 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-08-09 AccNo: 0001144204-18-043302 Size: 180 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-05-16 AccNo: 0001144204-18-029073 Size: 184 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submissi...
$Celcuity Inc.(CELC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-05-14 AccNo: 0001144204-18-028226 Size: 3 MB 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-05-14 AccNo: 0001144204-18-028195 Size: 124 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-04-06 AccNo: 0001144204-18-019634 Size: 25 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 7.01: Regulatio...
$Celcuity Inc.(CELC)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-03-27 AccNo: 0001144204-18-017208 Size: 276 KB 网页链接
$Celcuity Inc.(CELC)$ DEF 14A - Other definitive proxy statements Filed: 2018-03-27 AccNo: 0001144204-18-017191 Size: 510 KB 网页链接
$Celcuity Inc.(CELC)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-03-27 AccNo: 0001144204-18-017208 Size: 276 KB 网页链接
$Celcuity Inc.(CELC)$ DEF 14A - Other definitive proxy statements Filed: 2018-03-27 AccNo: 0001144204-18-017191 Size: 510 KB 网页链接
$Celcuity Inc.(CELC)$ PRE 14A - Other preliminary proxy statements Filed: 2018-03-16 AccNo: 0001144204-18-015297 Size: 510 KB 网页链接